Systems Biology of Tumor Dormancy: Linking Biology and Mathematics on Multiple Scales to Improve Cancer Therapy
Open Access
- 30 April 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (9) , 2172-2175
Abstract
For many decades, it has been appreciated that tumor progression is not monotonic, and development of a cancer cell does not equate to inevitable cancer presentation in the clinic. Tumor progression is challenged by numerous intrinsic and extrinsic bottlenecks that can hold the tumor in dormant stages for prolonged periods. Given the complex, multiscale nature of these bottlenecks, the Center of Cancer Systems Biology organized a workshop on critical issues of systems biology of tumor dormancy. The program for the meeting this past July, chaired by N. Almog and H. Enderling, included discussions and interactive breakout sessions on regulation of tumor dormancy by angiogenesis, tumor–immune system interactions, cancer stem cell kinetics, and cell signaling pathways. Three important conclusions emerged from the meeting. The first was the urgent need to differentiate between tumor cell and tumor population dormancy of the primary tumor and metastatic deposits, the second was the continued need for interdisciplinary dialogs, and the third was the need to bring cross-scale mechanistic thinking to the field to achieve a more robust understanding of tumor dormancy and its clinical implications. Cancer Res; 72(9); 2172–5. ©2012 AACR.Keywords
This publication has 25 references indexed in Scilit:
- ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual DiseaseClinical Cancer Research, 2011
- Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150Blood, 2011
- Notch3 signalling promotes tumour growth in colorectal cancerThe Journal of Pathology, 2011
- Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cellsLeukemia, 2011
- Does tumour dormancy offer a therapeutic target?Nature Reviews Cancer, 2010
- MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent MechanismsGenes & Cancer, 2010
- Ligand-driven activation of the Notch pathway in T-all and solid tumors: Why Not(ch)?Cell Cycle, 2010
- Reversing Cancer From Inside and Out: Oncogene Addiction, Cellular Senescence, and the Angiogenic SwitchLymphatic Research and Biology, 2008
- Identification of cells initiating human melanomasNature, 2008
- Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesisThe FASEB Journal, 2006